SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-094877
Filing Date
2023-04-07
Accepted
2023-04-07 12:17:57
Documents
5
Period of Report
2023-05-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A d472886ddef14a.htm DEF 14A 367361
2 GRAPHIC g472886g73v05.jpg GRAPHIC 2461
3 GRAPHIC g472886g79e65.jpg GRAPHIC 4295
4 GRAPHIC g472886g98g92.jpg GRAPHIC 7431
5 GRAPHIC g472886g99v90.jpg GRAPHIC 8172
  Complete submission text file 0001193125-23-094877.txt   399814
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

IRS No.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38997 | Film No.: 23808267
SIC: 2834 Pharmaceutical Preparations